Download Full eBooks in PDF
Treating Tobacco Use And Dependence Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Treating Tobacco Use And Dependence book. This book definitely worth reading, it is an incredibly well-written.
Author : Anonim
Publisher : DIANE Publishing
Page : 276 pages
File Size : 53,9 Mb
Release : 2009
Category : Nicotine addiction
ISBN : 9781437906622
Author : Michael Fiore
Publisher : Department of Health and Human Services Public Health Servic
Page : 200 pages
File Size : 52,9 Mb
Release : 2000
Category : Nicotine addiction
ISBN : UOM:39015052466078
"This guideline is an updated version of the 1996 Smoking Cessation Clinical Practice Guideline No. 18."--P. ii.
Author : United States Government Printing Office
Publisher : Health and Human Services Department
Page : 179 pages
File Size : 53,9 Mb
Release : 2000
Category : Electronic government information
ISBN : 0160504813
Author : Institute of Medicine,Board on Health Care Services,National Cancer Policy Forum
Publisher : National Academies Press
Page : 131 pages
File Size : 55,7 Mb
Release : 2013-05-16
Category : Medical
ISBN : 9780309264013
Tobacco use is the leading cause of preventable death in United States, causing more than 440,000 deaths annually and resulting in $193 billion in health-related economic losses each year-$96 billion in direct medical costs and $97 billion in lost productivity. Since the first U.S. Surgeon General's report on smoking in 1964, more than 29 Surgeon General's reports, drawing on data from thousands of studies, have documented the overwhelming and conclusive biologic, epidemiologic, behavioral, and pharmacologic evidence that tobacco use is deadly. This evidence base links tobacco use to the development of multiple types of cancer and other life-threatening conditions, including cardiovascular and respiratory diseases. Smoking accounts for at least 30 percent of all cancer deaths, and 80 percent of lung cancer deaths. Despite the widespread agreement on the dangers of tobacco use and considerable success in reducing tobacco use prevalence from over 40 percent at the time of the 1964 Surgeon General's report to less than 20 percent today, recent progress in reducing tobacco use has slowed. An estimated 18.9 percent of U.S. adults smoke cigarettes, nearly one in four high school seniors smoke, and 13 percent of high school males use smokeless tobacco products. In recognition that progress in combating cancer will not be fully achieved without addressing the tobacco problem, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened a public workshop, Reducing Tobacco-Related Cancer Incidence and Mortality, June 11-12, 2012 in Washington, DC. In opening remarks to the workshop participants, planning committee chair Roy Herbst, professor of medicine and of pharmacology and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital, described the goals of the workshop, which were to examine the current obstacles to tobacco control and to discuss potential policy, outreach, and treatment strategies that could overcome these obstacles and reduce tobacco-related cancer incidence and mortality. Experts explored a number of topics, including: the changing demographics of tobacco users and the changing patterns of tobacco product use; the influence of tobacco use on cancer incidence and cancer treatment outcomes; tobacco dependence and cessation programs; federal and state level laws and regulations to curtail tobacco use; tobacco control education, messaging, and advocacy; financial and legal challenges to tobacco control efforts; and research and infrastructure needs to support tobacco control strategies, reduce tobacco related cancer incidence, and improve cancer patient outcomes. Reducing Tobacco-Related Cancer Incidence and Mortality summarizes the workshop.
Author : Michelle N. Eakin,Hasmeena Kathuria
Publisher : Springer Nature
Page : 302 pages
File Size : 50,6 Mb
Release : 2023-02-28
Category : Medical
ISBN : 9783031249143
This book is a guide to pharmacotherapy treatment of tobacco dependence. The 2020 American Thoracic Society clinical practice guidelines on treating tobacco dependence serves as the cornerstone for this work with its robust discussion of recommended treatment options and how to tailor treatment to specific patient populations. Tobacco dependence remains a major health concern for many adults and given the dramatic increase of youth electronic cigarette use, clinicians need a singular resource to treat these different populations. This book addresses that by following the three main points of how to best address the adverse impact of tobacco use on public health: 1) prevent initiation of tobacco use; 2) understand mechanisms of addiction; 3) effectively treat tobacco dependence. The book begins by describing the current patterns of product use, the adverse impact of tobacco on global health, and tobacco-related health disparities. Authors discuss both combustible and electronic tobacco products, as well as current research on the adverse impact of vaping and associated flavorings including menthol, role of the e-cigarette in cessation, and treatment of adolescent nicotine dependence. Chapters conclude with a discussion of specific tobacco control policies to improve overall public health. This is an ideal guide for pulmonologists, pediatricians, primary care physicians and other specialty providers who see patients with nicotine dependence. This book is also of interest to public health professions to help inform public health campaigns and treatment offerings to reduce overall tobacco product use through prevention and treatment.
Author : U. S. Department Human Services,Department of Health and Human Services,Public Health Service
Publisher : CreateSpace
Page : 36 pages
File Size : 50,7 Mb
Release : 2013-06-21
Category : Medical
ISBN : 1490500464
The Quick Reference Guide for Clinicians contains strategies and recommendations from the Public Health Service-sponsored Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update. The guideline was designed to assist clinicians; smoking cessation specialists; and healthcare administrators, insurers, and purchasers in identifying and assessing tobacco users and in delivering effective tobacco dependence interventions. It was based on an exhaustive systematic review and analysis of the extant scientific literature from 1975–2007 and uses the results of more than 50 meta-analyses. The Quick Reference Guide for Clinicians summarizes the guideline strategies for providing appropriate treatments for every patient. Effective treatments for tobacco dependence now exist, and every patient should receive at least minimal treatment every time he or she visits a clinician. The first step in the process—identification and assessment of tobacco use status—separates patients into three treatment categories: (1) tobacco users who are willing to quit should receive intervention to help in their quit attempt; (2) those who are unwilling to quit now should receive interventions to increase their motivation to quit; and (3) those who recently quit using tobacco should be provided relapse prevention treatment. Tobacco is the single greatest cause of disease and premature death in America today, and is responsible for more than 435,000 deaths annually. About 20 percent of adult Americans currently smoke, and 4,000 children and adolescents smoke their first cigarette each day. The societal costs of tobacco related death and disease approach $96 billion annually in medical expenses and $97 billion in lost productivity. However, more than 70 percent of all current smokers have expressed a desire to stop smoking; if they successfully quit, the result will be both immediate and long-term health improvements. Clinicians have a vital role to play in helping smokers quit. The analyses contained within the Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update demonstrated that efficacious treatments for tobacco users exist and should become a part of standard care giving. Research also shows that delivering such treatments is cost-effective. In summary, the treatment of tobacco use and dependence presents the best and most cost-effective opportunity for clinicians to improve the lives of millions of Americans nationwide.
Author : Tobacco Use and Dependence Panel,U. S. Department of Health
Publisher : www.Militarybookshop.CompanyUK
Page : 276 pages
File Size : 49,8 Mb
Release : 2008-05-01
Category : Self-Help
ISBN : 1780397917
"Treating Tobacco Use and Dependence: 2008 Update," a Public Health Service-sponsored Clinical Practice Guideline, is a product of the Tobacco Use and Dependence Guideline Panel ("the Panel"), consortium representatives, consultants, and staff. These 37 individuals were charged with the responsibility of identifying effective, experimentally validated tobacco dependence treatments and practices. The updated Guideline was sponsored by a consortium of eight Federal Government and nonprofit organizations: the Agency for Healthcare Research and Quality (AHRQ); Centers for Disease Control and Prevention (CDC); National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Drug Abuse (NIDA); American Legacy Foundation; Robert Wood Johnson Foundation (RWJF); and University of Wisconsin School of Medicine and Public Health's Center for Tobacco Research and Intervention (UW-CTRI). This Guideline is an updated version of the 2000 Treating Tobacco Use and Dependence: Clinical Practice Guideline that was sponsored by the U.S. Public Health Service, U. S. Department of Health and Human Services.
Author : Alan L Peterson,Mark W. Vander Weg,Carlos R. Jaén
Publisher : Hogrefe Publishing GmbH
Page : 135 pages
File Size : 55,5 Mb
Release : 2011-01-01
Category : Psychology
ISBN : 9781613343241
This volume in the series Advances in Psychotherapy – Evidence-Based Practice provides health care providers with practical and evidence-based guidance on the diagnosis and treatment of nicotine and tobacco dependence. Tobacco use is the leading preventable cause of death in the world, and it is the only legally available consumer product that kills people when used entirely as intended. Research over the past several decades has led to the development of a number of evidence-based treatments for nicotine and tobacco dependence that can be delivered by health care professionals in a variety of primary and specialty care settings. This book aims to increase medical, mental health, and dental practitioners' access to empirically supported interventions for nicotine and tobacco dependence, with the hope that these methods will be incorporated into routine clinical practice. The book is both a compact "how-to" reference for clinicians and an ideal educational resource for students and for practice-oriented continuing education. The volume includes tables, boxed clinical pearls, and clinical vignettes, and the appendix includes clinical tools, patient handouts, and links to the top recommended websites for the download of additional patient materials.
Author : Anonim
Publisher : Unknown
Page : 728 pages
File Size : 46,7 Mb
Release : 2010
Category : Government publications
ISBN : UCSD:31822037817723
This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.
Author : Michael C. Fiore
Publisher : Unknown
Page : 179 pages
File Size : 45,7 Mb
Release : 2005-05
Category : Electronic
ISBN : 0756747481
This Public Health Service-sponsored guideline is the result of an extraordinary partnership among Federal Gov't. & nonprofit organizations comprised of the Agency for Healthcare Research & Quality; Centers for Disease Control & Prevention; Nat. Cancer Institute; Nat. Heart, Lung, & Blood Institute; Nat. Institute on Drug Abuse; Robert Wood Johnson Found.; & the Univ. of Wisconsin Med. School's Center for Tobacco Research & Intervention. This guideline is an updated version of the 1996 Smoking Cessation Clinical Practice Guideline No. 18.Ó It is the product of a private-sector panel of experts, consortium representatives, & staff. The panel's recommendations are primarily based on published, evidence-based research. Illus.
Author : Institute of Medicine,Board on Population Health and Public Health Practice,Committee on Smoking Cessation in Military and Veteran Populations
Publisher : National Academies Press
Page : 380 pages
File Size : 40,5 Mb
Release : 2009-11-21
Category : Medical
ISBN : 9780309137676
The health and economic costs of tobacco use in military and veteran populations are high. In 2007, the Department of Veterans Affairs (VA) and the Department of Defense (DoD) requested that the Institute of Medicine (IOM) make recommendations on how to reduce tobacco initiation and encourage cessation in both military and veteran populations. In its 2009 report, Combating Tobacco in Military and Veteran Populations, the authoring committee concludes that to prevent tobacco initiation and encourage cessation, both DoD and VA should implement comprehensive tobacco-control programs.
Author : Tobacco Free Initiative (Organisation mondiale de la santé)
Publisher : World Health Organization
Page : 107 pages
File Size : 44,5 Mb
Release : 2003
Category : Medical
ISBN : 9789241562409
Along with an individual approach (behavioural and/or pharmacological interventions) to smoking cessation and treatment of tobacco dependence, a supportive environment is needed to encourage tobacco consumers in their attempts to quit. Treatment of tobacco dependence should be part of a comprehensive tobacco-control policy along with measures such as taxation and price policies, advertising restrictions, dissemination of information and establishment of smoke-free public places. The recommendations contained in this book propose a broad framework for addressing smoking cessation and treatment of tobacco dependence. In this framework, Governments can progressively choose minimal, expanded and core recommendations as they strengthen their resources and capacities.
Author : David B. Abrams,Raymond Niaura
Publisher : Guilford Press
Page : 146 pages
File Size : 44,8 Mb
Release : 2003-02-12
Category : Psychology
ISBN : 1572308494
This unique clinical handbook offers the knowledge, skills, and materials needed to help all types of smokers, even the most hard-core, successfully quit. Provided are assessment tools, treatment planning guidelines, and a series of complete treatment packages, ranging from ultra-brief to more intensive options. Designed for use in a variety of settings by a wide range of providers, the volume is evidence-based and consistent with the latest national guidelines on best practice. The authors, leading scientist-practitioners, incorporate the latest pharmacotherapeutic approaches as well as proven motivational, cognitive, and behavioral techniques. Strategies are presented for tailoring treatment to individual smokers and for preventing relapse. Also included are session-by-session intervention guidelines, helpful case examples, and dozens of requisite handouts and forms, ready to photocopy and use. Key Features No other book presents the full range of empirically supported treatments. Practical: includes step-by-step guidelines, cases, reproducible patient forms. Consistent with best-practice recommendations issued by the Surgeon General, the American Psychiatric Association, and the British Thoracic Society. Describes approaches with and without pharmacotherapy. Photocopy Rights: The Publisher grants individual book purchasers nonassignable permission to reproduce selected materials in this book for professional use. For details and limitations, see copyright page.
Author : Michael Fiore
Publisher : Department of Health and Human Services Public Health Servic
Page : 256 pages
File Size : 40,5 Mb
Release : 2008-01-01
Category : Nicotine addiction
ISBN : 1587633515
Author : U. S. Department Human Services,Public Service
Publisher : CreateSpace
Page : 276 pages
File Size : 55,8 Mb
Release : 2013-06-21
Category : Electronic
ISBN : 1490500510
"Treating Tobacco Use and Dependence: 2008 Update"," is a product of the Tobacco Use and Dependence Guideline Panel, consortium representatives, consultants, and staff. This Guideline is an updated version that contains strategies and recommendations designed to assist clinicians; tobacco dependence treatment specialists; and health care administrators, insurers, and purchasers in delivering and supporting effective treatments for tobacco use and dependence. The recommendations were made as a result of a systematic review and meta-analysis of 11 specific topics identified by the Panel. The key recommendations of the updated Guideline are as follows: The overarching goal of these recommendations is that clinicians strongly recommend the use of effective tobacco dependence counseling and medication treatments to their patients who use tobacco, and that health systems, insurers, and purchasers assist clinicians in making such effective treatments available. 1. Tobacco dependence is a chronic disease that often requires repeated intervention and multiple attempts to quit. Effective treatments exist, however, that can significantly increase rates of long-term abstinence. 2. It is essential that clinicians and health care delivery systems consistently identify and document tobacco use status and treat every tobacco user seen in a health care setting. 3. Tobacco dependence treatments are effective across a broad range of populations. Clinicians should encourage every patient willing to make a quit attempt to use the counseling treatments and medications recommended in this Guideline. 4. Brief tobacco dependence treatment is effective. Clinicians should offer every patient who uses tobacco at least the brief treatments shown to be effective in this Guideline. 5. Individual, group, and telephone counseling are effective, and their effectiveness increases with treatment intensity. Two components of counseling are especially effective, and clinicians should use these when counseling patients making a quit attempt: Practical counseling (problemsolving/skills training); Social support delivered as part of treatment 6. Numerous effective medications are available for tobacco dependence, and clinicians should encourage their use by all patients attempting to quit smoking-except when medically contraindicated or with specific populations for which there is insufficient evidence of effectiveness (i.e., pregnant women, smokeless tobacco users, light smokers, and adolescents). Seven first-line medications (5 nicotine and 2 non-nicotine) reliably increase long-term smoking abstinence rates: Bupropion SR, Nicotine gum, Nicotine inhaler, Nicotine lozenge, Nicotine nasal spray, Nicotine patch, Varenicline; Clinicians also should consider the use of certain combinations of medications identified as effective in this Guideline. 7. Counseling and medication are effective when used by themselves for treating tobacco dependence. The combination of counseling and medication, however, is more effective than either alone. Thus, clinicians should encourage all individuals making a quit attempt to use both counseling and medication. 8. Telephone quitline counseling is effective with diverse populations and has broad reach. Therefore, both clinicians and health care delivery systems should ensure patient access to quitlines and promote quitline use. 9. If a tobacco user currently is unwilling to make a quit attempt, clinicians should use the motivational treatments shown in this Guideline to be effective in increasing future quit attempts. 10. Tobacco dependence treatments are both clinically effective and highly cost-effective relative to interventions for other clinical disorders. Providing coverage for these treatments increases quit rates. Insurers and purchasers should ensure that all insurance plans include the counseling and medication identified as effective in this Guideline as covered benefits.
